MET - NYSE

MetLife, Inc.

MET·NYSE

$80.96

-2.2%

Financial ServicesInsurance - Life

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$52.09B

EPS4.8000

P/E Ratio16.87

Earnings Date08/05/2026

745.17B

Assets

10%

3Y+12.0%

5Y-6.0%

10Y-17.0%

716.25B

Total Liabilities

10%

3Y+13.0%

5Y-1.0%

10Y-14.0%

28.92B

Total Equity

3Y-4.0%

5Y-61.0%

10Y-57.0%

MetLife, Inc. Funding & Solvency Profile

MET · NYSE

Current Assets

Cash & Cash Equivalents22.03B

Net Receivables54.25B

Inventory0.00

Other Current Assets0.00

Total Current Assets180 B

Non-Current Assets

Property, Plant & Equipment1.70B

Goodwill & Intangible Assets30.72B

Long-Term Investments362.81B

Other Non-Current Assets167.77B

Total Non-Current Assets532 B

Total Assets

745.17B

Financial Health Analysis

Current Ratio

0.65x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Debt-to-Equity Ratio

24.77x

High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.

Working Capital

-96549000000

Negative working capital indicates short-term liabilities exceed short-term assets—potential liquidity stress.

Asset Composition

24% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Financial stress indicators: Both liquidity and leverage metrics raise concerns. The company may face challenges meeting obligations and should focus on strengthening its balance sheet.

MetLife, Inc. Balance Sheet

MET • NYSE

MetLife, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	22B	20.1B	20.6B	20.2B	20B	19.8B	16.6B	15.8B	12.7B	12.7B	12.8B	10.8B	7.6B	15.7B	10.5B	13B	10.1B	24.2B	10B	7.1B
Short-Term Investments	103.3B	88.7B	296.2B	293.1B	347.5B	358.7B	331.7B	302.2B	313.8B	299B	364B	377.7B	367.5B	394.1B	17.3B	9.4B	8.4B	13.9B	3.3B	2.7B
Cash & Short-Term Investments	125.3B	108.8B	316.8B	313.3B	367.5B	378.5B	348.3B	19.8B	326.5B	311.6B	376.8B	388.5B	375.1B	409.8B	27.8B	22.4B	18.5B	38.1B	13.3B	9.8B
Net Receivables	54.3B	34.3B	33.8B	22.2B	20.5B	17.9B	20.4B	19.6B	18.4B	15.5B	22.9B	22.2B	21.9B	21.6B	22.5B	19.8B	17.1B	17B	13.4B	14.5B
Accounts Receivables	49.2B	29.8B	29B	17.4B	17.1B	17.9B	20.4B	19.6B	18.4B	15.4B	22.7B	22.2B	21.9B	21.6B	22.5B	19.8B	16.8B	17B	13.4B	14.5B
Other Receivables	5.1B	4.5B	4.8B	4.8B	3.4B	0.0	0.0	0.0	0.0	0.0	161M	0.0	0.0	0.0	0.0	0.0	316M	0.0	0.0	0.0
Other Current Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-16.1B	-323.8B	-289.1B	-22.9B	-22.2B	-26.5B	395.4B	737.4B	676.9B	498.7B	441.6B	527B	498.5B
Total Current Assets	179.6B	143B	350.6B	335.5B	388B	396.4B	368.7B	23.3B	21.1B	37.9B	376.8B	388.5B	370.5B	826.8B	787.7B	719.1B	534.3B	496.7B	553.7B	522.8B
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	1.7B	1.9B	2B	1.9B	0.0	2.8B	2.8B	2.6B	0.0	2.4B	0.0	0.0	1B	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Goodwill	9.6B	8.9B	9.2B	9.3B	9.5B	10.1B	9.3B	9.4B	9.6B	9.2B	9.5B	9.9B	10.5B	10B	11.9B	11.8B	5B	5B	4.8B	4.9B
Intangible Assets	21.1B	19.6B	20.2B	19.7B	16.1B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Goodwill & Intangible Assets	30.7B	28.5B	29.4B	29B	25.6B	10.1B	9.3B	9.4B	9.6B	9.2B	9.5B	9.9B	10.5B	10B	11.9B	11.8B	5B	5B	4.8B	4.9B
Long-Term Investments	362.8B	346.7B	144.2B	134.8B	147.4B	149.8B	142.1B	134B	0.0	368.7B	131B	127.7B	120.6B	123B	0.0	461.7B	326.1B	292B	321.5B	0.0
Tax Assets	2.6B	3B	2.6B	2.4B	189M	0.0	0.0	5B	6.8B	0.0	6.2B	8.1B	5.7B	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Assets	167.8B	154.4B	158.8B	159.4B	198.5B	612.6B	569.6B	513.2B	0.0	-7.5B	705.1B	733.2B	377B	-123B	0.0	-461.7B	-326.1B	-292B	-79.9B	0.0
Total Non-Current Assets	565.6B	534.4B	337B	327.6B	371.7B	775.4B	723.9B	664.2B	16.4B	372.8B	851.9B	878.8B	514.8B	10B	11.9B	11.8B	5B	5B	246.4B	4.9B
Other Assets	0.0	0.0	0.0	0.0	0.0	-376.6B	-352.1B	0.0	-8.4B	-8.3B	-350.7B	-364.9B	0.0	0.0	0.0	0.0	0.0	0.0	-240.9B	0.0
Total Assets	745.2B	677.5B	687.6B	663.1B	759.7B	795.1B	740.5B	687.5B	719.9B	898.8B	877.9B	902.3B	885.3B	836.8B	799.6B	730.9B	539.3B	501.7B	559.1B	527.7B
LIABILITIES
CURRENT LIABILITIES
Total Payables	17.1B	17.1B	17.5B	20.9B	31.9B	716M	1B	1.1B	993M	696M	720M	868M	861M	1.1B	967M	316M	761M	1.4B	2.4B	3.5B
Accounts Payable	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	789M	2B
Other Payables	17.1B	17.1B	17.5B	20.9B	31.9B	716M	1B	1.1B	993M	696M	720M	868M	861M	1.1B	967M	316M	761M	1.4B	3.1B	1.5B
Short Term Debt	1.6B	465M	119M	175M	341M	393M	235M	268M	477M	242M	100M	100M	175M	100M	686M	306M	912M	2.7B	667M	1.4B
Tax Payables	0.0	0.0	190M	42M	0.0	129M	363M	441M	311M	20M	161M	184M	186M	401M	193M	316M	0.0	342M	0.0	1.5B
Other Current Liabilities	257.5B	240.5B	239.9B	230B	230.9B	-716M	-1B	24.1B	25B	-938M	36.2B	34.6B	-1B	-992M	-967M	-316M	-761M	-4B	44.1B	47.4B
Total Current Liabilities	276.1B	258.1B	257.6B	251.1B	263.2B	393M	235M	25.5B	26.5B	0.0	37B	35.6B	0.0	237M	686M	306M	912M	35.8B	47.2B	52.4B
NON-CURRENT LIABILITIES
Long Term Debt	18.6B	18.2B	18.7B	17.7B	17.1B	17.8B	16.6B	16B	20B	20.9B	21.2B	19.5B	21.8B	22.3B	26.8B	36.1B	21.7B	13.4B	13.2B	12.9B
Deferred Tax Liabilities (Non-Current)	536M	132M	927M	950M	9.7B	11B	9.1B	0.0	6.8B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5B	2.3B
Other Non-Current Liabilities	420.9B	373.3B	380.1B	363.1B	402B	691.6B	648.4B	618.6B	607.8B	810.2B	788.2B	810.2B	800.5B	-66M	711.8B	-14.2B	464.5B	461.9B	508B	477.3B
Total Non-Current Liabilities	440.1B	391.7B	399.8B	381.9B	428.8B	720.3B	674.1B	634.6B	634.5B	831.1B	809.4B	829.7B	822.3B	22.2B	738.7B	21.9B	486.2B	475.3B	522.7B	492.5B
Other Liabilities	0.0	0.0	0.0	0.0	0.0	-393M	-235M	-25.5B	0.0	0.0	-37B	-35.6B	0.0	749.4B	710.7B	659.6B	18.7B	-33.4B	-45.9B	-50.9B
Capital Lease Obligations	6M	6M	32M	56M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33M	37M	0.0	0.0	0.0	0.0	0.0
Total Liabilities	716.2B	649.8B	657.3B	632.9B	692B	720.3B	674.1B	634.6B	661B	831.1B	809.4B	829.7B	822.3B	771.8B	748.4B	681.8B	505.8B	477.7B	524B	493.9B
SHAREHOLDERS' EQUITY
Treasury Stock	-30.7B	-27.8B	-24.6B	-21.5B	-18.2B	-13.8B	-12.7B	-10.4B	-6.4B	-3.5B	-3.1B	-1.2B	-172M	-172M	-172M	-172M	-190M	-236M	-2.9B	-1.4B
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1M	1M	1M	1M	1M	1M	1M	1M	1M
Common Stock	12M	12M	12M	12M	12M	12M	12M	12M	12M	12M	12M	12M	11M	11M	11M	10M	8M	8M	8M	8M
Additional Paid-In Capital	32.9B	33.8B	33.7B	33.6B	33.5B	33.8B	32.7B	32.5B	31.1B	30.9B	30.7B	30.5B	29.3B	28B	26.8B	26.4B	16.9B	15.8B	17.1B	17.5B
Retained Earnings	44.3B	42.6B	40.1B	40.3B	41.2B	36.5B	33.1B	28.9B	26.5B	34.7B	35.5B	32B	27.3B	25.2B	24.8B	21.4B	19.5B	22.4B	19.9B	16.6B
Accumulated Other Comprehensive Income/Loss	-18.1B	-21.2B	-19.2B	-22.6B	10.9B	18.1B	13.1B	1.7B	7.4B	5.4B	4.8B	10.6B	5.1B	11.4B	5.9B	1B	-3.1B	-14.3B	1.1B	1.1B
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	394M	0.0	0.0	0.0	0.0	0.0
Total Stockholders' Equity	28.4B	27.4B	30B	29.9B	67.5B	74.6B	66.1B	52.7B	58.7B	67.5B	67.9B	72.1B	61.6B	64.5B	57.5B	48.6B	33.1B	23.7B	35.2B	33.8B
Total Equity	28.9B	27.7B	30.3B	30.1B	67.7B	74.8B	66.4B	53B	58.9B	67.7B	68.5B	72.7B	63B	65B	58B	49.1B	33.5B	23.7B	35.2B	33.8B
Minority Interest	523M	258M	238M	244M	267M	259M	238M	217M	194M	171M	547M	606M	1.4B	505M	479M	488M	377M	0.0	0.0	0.0
SUMMARY
Total Liabilities & Equity	745.2B	677.5B	687.6B	663.1B	759.7B	795.1B	740.5B	687.5B	719.9B	898.8B	877.9B	902.3B	885.3B	836.8B	799.6B	730.9B	539.3B	501.7B	558.6B	527.7B
Total Investments	466.1B	435.4B	440.4B	428B	494.8B	508.5B	473.8B	436.2B	313.8B	667.7B	495.5B	506B	488.8B	517.1B	17.3B	471.1B	334.5B	305.9B	324.8B	2.7B
Total Debt	20.2B	18.7B	18.8B	18B	17.4B	18.1B	16.9B	16.2B	19.3B	21.1B	21.3B	19.6B	22B	22.4B	27.6B	36.4B	22.6B	16.1B	13.8B	14.4B
Net Debt	-1.8B	-1.4B	-1.8B	-2.2B	-2.6B	-1.6B	253M	423M	6.6B	7.2B	8.6B	8.8B	14.4B	6.6B	17.1B	23.3B	12.5B	-8.1B	3.9B	7.3B
Shares Outstanding	658,898,980	658,898,980	658,898,980	658,898,980	658,898,980	658,898,980	658,898,980	658,898,980	658,898,980	658,898,980	658,898,980	658,898,980	658,898,980	658,898,980	658,898,980	658,898,980	658,898,980	658,898,980	658,898,980	658,898,980

SEC Filings

MET - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 15, 2026	May 15, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 07, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 06, 2026	May 06, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 29, 2026	June 16, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 07, 2026	April 07, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 05, 2026	March 05, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 26, 2026	February 24, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 24, 2026	February 24, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 19, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 17, 2026	February 17, 2026	2026	View Filing

Showing 1 to 10 of 831 filings

Related Guides

Blog Categories

Continue your MET research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.